Pharmaceutical composition containing tamsulosin hydrochloride with excellent acid resistance and preparation method therefor

A technology of tamsulosin hydrochloride and composition, which is applied in the field of pharmaceutical compositions containing tamsulosin hydrochloride, can solve the problems of low dissolution rate changes, and achieve the effects of low dissolution rate, good acid resistance and low friability

Pending Publication Date: 2021-09-03
HANMI PHARMA
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The pharmaceutical formulation provided by Patent Document 2 has

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition containing tamsulosin hydrochloride with excellent acid resistance and preparation method therefor
  • Pharmaceutical composition containing tamsulosin hydrochloride with excellent acid resistance and preparation method therefor
  • Pharmaceutical composition containing tamsulosin hydrochloride with excellent acid resistance and preparation method therefor

Examples

Experimental program
Comparison scheme
Effect test

Embodiment approach

[0145] According to an embodiment of the invention, oral clothing is prepared by the following

[0146] a) Provide core beads;

[0147] b) Preparation of post-mixture containing disintegrants and buffers;

[0148] c) The resulting mixture was pressed after mixed core beads, post mixtures, and additives.

[0149] First, the core beads used in step a) are the core beads of the above-mentioned various shapes.

[0150] According to another embodiment of the present invention, a new pharmaceutical composition comprising Tanlo-containing hydrochloric acid is prepared by preparing a hydrochloric acid.

[0151] Preparation of core beads containing Tanlo hydrochloride;

[0152] The surface of the core bead is covered with a coating liquid containing the sustained release to prepare a sustained-release core;

[0153] The sustained-release core beads are coated with an enteric coating coated coat coating containing an enteric polymer and a plasticizer to prepare an enteric coating suegerage ...

preparation example 1

[0166] Preparation Example 1 Preparation of Switzer Beads

[0167] Preparation of core beads containing Tanlo hydrochloride and sustained release coating.

[0168] First, the hydroxypropyl methylcellulose (HPMC), ethanol and purified water as the binder are mixed in the high-speed mixer, and then talc powder is mixed in the high-speed mixer. Medium in the production of coated liquid. The microcrystalline cellulose (MCC, Cellets 175, particle size distribution of 150 μm to 200 μm) is placed in a fluidized bed coating machine as an inert seed, and a coating liquid is sprayed by a bottom spray process. After the coating was sprayed, the resulting material was dried to prepare core beads containing Tanlo hydrochloride.

[0169] In order to prepare a sustained release coating layer on the surface of the core, the sustained release agent SR 30d (EP) was dissolved in water and talcumed pulp was added thereto to produce sustained release coating liquid. The prepared core bead is placed i...

experiment example 1

[0171] Experimental Example 1: Physical properties between drugs according to the plasticizer content

[0172] Pills are manufactured by a compact-soluble sustained and release core bead having a sustained release coating layer by a tablet. During the press, the enteric coating layer is damaged, so the acid resistance is deteriorated. According to the present invention, acid resistance can be improved by adding a plasticizer. In the present experiment, each pill was produced by changing the content of the plasticizer, and the physical properties of the prepared pills were quoted.

[0173] (1) Preparation of the pill

[0174] Pieces were prepared according to the composition shown in Table 2. As the core bead, the slow-release core bead prepared according to the Preparation Example 1 is used.

[0175] Eudragit L30-D55 and Eudragit NE30D were used as enteric coating materials and triethyl citrate was used as plasticizers. The Eudragit L30-D55 and Eudragit NE30D were dissolved in th...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Wavelengthaaaaaaaaaa
Login to view more

Abstract

The present invention relates to a pharmaceutical composition containing tamsulosin hydrochloride with excellent acid resistance and a preparation method therefor, and to a pharmaceutical composition in which, by coating prepared core beads, which comprise tamsulosin hydrochloride as an active ingredient, with an enteric coating liquid prepared using a certain amount of a plasticizer, adding a buffer base and the like to adjust density, and then mixing and tableting a mixed portion and a lubricant, even after the tableting, the enteric coating is not broken and acid resistance is maintained. Thus, the present invention has good tabletability, excellent content uniformity, excellent acid resistance due to a low dissolution rate of tamsulosin hydrochloride, and no significant decomposition of tamsulosin hydrochloride, and thus, stability can be ensured.

Description

Technical field [0001] The present invention relates to a pharmaceutical composition comprising excellent acid resistance and a new pharmaceutical composition thereof. Background technique [0002] Tanoli in hydrochloride is a drug that selectively acts on the urinary reproductive system by selectively blocking alpha-adrenergic receptors. Specifically, it increases the excretion ratio of urine by relaxing smooth muscle around the bladder and prostate, and treats symptomatic benign prostate hyperplasia. Tanlo new exhibits a good effect and less side effects. [0003] The new bioavailability of Tanoli, which is 90% or greater than 90%, thereby absorbing well in the body. The new half-life of Tanlo was 9 to 13 hours in the healthy human body, while in the body of a benign prostatic hyperplasia was 14 to 15 hours. Thus, tanolin new hydrochloride does not need to be supplied to a continuous sustained release formulation for more than 12 hours or 24 hours. When it is prepared to slow r...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/20A61K9/50A61K31/18
CPCA61K31/18A61K9/2081A61K9/5073A61K9/5026A61K9/2031A61K9/2013A61K9/2027A61K9/2054A61K9/20A61K9/50
Inventor 河恩镐李承俊林昊泽金用镒
Owner HANMI PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap